Cargando…

Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis

Salvianolic acid A (SAA) is one of bioactive polyphenol extracted from a Salvia miltiorrhiza (Danshen), which was widely used to treat cardiovascular disease in traditional Chinese medicine. SAA has been reported to be protective in cardiovascular disease and ischemia injury, with anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiang, Zhu, Cheng-long, Li, Hui-ru, Xie, Jian, Guo, Yu, Li, Peng, Zhao, Zhen-zhen, Wang, Jia-feng, Deng, Xiao-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334034/
https://www.ncbi.nlm.nih.gov/pubmed/35910849
http://dx.doi.org/10.1155/2022/7411824
_version_ 1784759010174435328
author Liu, Qiang
Zhu, Cheng-long
Li, Hui-ru
Xie, Jian
Guo, Yu
Li, Peng
Zhao, Zhen-zhen
Wang, Jia-feng
Deng, Xiao-ming
author_facet Liu, Qiang
Zhu, Cheng-long
Li, Hui-ru
Xie, Jian
Guo, Yu
Li, Peng
Zhao, Zhen-zhen
Wang, Jia-feng
Deng, Xiao-ming
author_sort Liu, Qiang
collection PubMed
description Salvianolic acid A (SAA) is one of bioactive polyphenol extracted from a Salvia miltiorrhiza (Danshen), which was widely used to treat cardiovascular disease in traditional Chinese medicine. SAA has been reported to be protective in cardiovascular disease and ischemia injury, with anti-inflammatory and antioxidative effect, but its role in acute lung injury (ALI) is still unknown. In this study, we sought to investigate the therapeutic effects of SAA in a murine model of lipopolysaccharide- (LPS-) induced ALI. The optimal dose of SAA was determined by comparing the attenuation of lung injury score after administration of SAA at three different doses (low, 5 mg/kg; medium, 10 mg/kg; and, high 15 mg/kg). Dexamethasone (DEX) was used as a positive control for SAA. Here, we showed that the therapeutic effect of SAA (10 mg/kg) against LPS-induced pathologic injury in the lungs was comparable to DEX. SAA and DEX attenuated the increased W/D ratio and the protein level, counts of total cells and neutrophils, and cytokine levels in the BALF of ALI mice similarly. The oxidative stress was also relieved by SAA and DEX according to the superoxide dismutase and malondialdehyde. NET level in the lungs was elevated in the injured lung while SAA and DEX reduced it significantly. LPS induced phosphorylation of Src, Raf, MEK, and ERK in the lungs, which was inhibited by SAA and DEX. NET level and phosphorylation level of Src/Raf/MEK/ERK pathway in the neutrophils from acute respiratory distress syndrome (ARDS) patients were also inhibited by SAA and DEX in vitro, but the YEEI peptide reversed the protective effect of SAA completely. The inhibition of NET release by SAA was also reversed by YEEI peptide in LPS-challenged neutrophils from healthy volunteers. Our data demonstrated that SAA ameliorated ALI via attenuating inflammation, oxidative stress, and neutrophil NETosis. The mechanism of such protective effect might involve the inhibition of Src activation.
format Online
Article
Text
id pubmed-9334034
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93340342022-07-29 Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis Liu, Qiang Zhu, Cheng-long Li, Hui-ru Xie, Jian Guo, Yu Li, Peng Zhao, Zhen-zhen Wang, Jia-feng Deng, Xiao-ming Oxid Med Cell Longev Research Article Salvianolic acid A (SAA) is one of bioactive polyphenol extracted from a Salvia miltiorrhiza (Danshen), which was widely used to treat cardiovascular disease in traditional Chinese medicine. SAA has been reported to be protective in cardiovascular disease and ischemia injury, with anti-inflammatory and antioxidative effect, but its role in acute lung injury (ALI) is still unknown. In this study, we sought to investigate the therapeutic effects of SAA in a murine model of lipopolysaccharide- (LPS-) induced ALI. The optimal dose of SAA was determined by comparing the attenuation of lung injury score after administration of SAA at three different doses (low, 5 mg/kg; medium, 10 mg/kg; and, high 15 mg/kg). Dexamethasone (DEX) was used as a positive control for SAA. Here, we showed that the therapeutic effect of SAA (10 mg/kg) against LPS-induced pathologic injury in the lungs was comparable to DEX. SAA and DEX attenuated the increased W/D ratio and the protein level, counts of total cells and neutrophils, and cytokine levels in the BALF of ALI mice similarly. The oxidative stress was also relieved by SAA and DEX according to the superoxide dismutase and malondialdehyde. NET level in the lungs was elevated in the injured lung while SAA and DEX reduced it significantly. LPS induced phosphorylation of Src, Raf, MEK, and ERK in the lungs, which was inhibited by SAA and DEX. NET level and phosphorylation level of Src/Raf/MEK/ERK pathway in the neutrophils from acute respiratory distress syndrome (ARDS) patients were also inhibited by SAA and DEX in vitro, but the YEEI peptide reversed the protective effect of SAA completely. The inhibition of NET release by SAA was also reversed by YEEI peptide in LPS-challenged neutrophils from healthy volunteers. Our data demonstrated that SAA ameliorated ALI via attenuating inflammation, oxidative stress, and neutrophil NETosis. The mechanism of such protective effect might involve the inhibition of Src activation. Hindawi 2022-07-21 /pmc/articles/PMC9334034/ /pubmed/35910849 http://dx.doi.org/10.1155/2022/7411824 Text en Copyright © 2022 Qiang Liu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Qiang
Zhu, Cheng-long
Li, Hui-ru
Xie, Jian
Guo, Yu
Li, Peng
Zhao, Zhen-zhen
Wang, Jia-feng
Deng, Xiao-ming
Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis
title Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis
title_full Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis
title_fullStr Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis
title_full_unstemmed Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis
title_short Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis
title_sort salvianolic acid a protects against lipopolysaccharide-induced acute lung injury by inhibiting neutrophil netosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334034/
https://www.ncbi.nlm.nih.gov/pubmed/35910849
http://dx.doi.org/10.1155/2022/7411824
work_keys_str_mv AT liuqiang salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT zhuchenglong salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT lihuiru salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT xiejian salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT guoyu salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT lipeng salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT zhaozhenzhen salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT wangjiafeng salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis
AT dengxiaoming salvianolicacidaprotectsagainstlipopolysaccharideinducedacutelunginjurybyinhibitingneutrophilnetosis